Citigroup’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-400
| Closed | -$9.05K | – | 4874 |
|
|
2024
Q4 | $9.05K | Hold |
400
| – | – | ﹤0.01% | 4541 |
|
|
2024
Q3 | $9.85K | Hold |
400
| – | – | ﹤0.01% | 4489 |
|
|
2024
Q2 | $9.25K | Hold |
400
| – | – | ﹤0.01% | 4414 |
|
|
2024
Q1 | $9.63K | Hold |
400
| – | – | ﹤0.01% | 4450 |
|
|
2023
Q4 | $9.2K | Hold |
400
| – | – | ﹤0.01% | 4447 |
|
|
2023
Q3 | $8.14K | Hold |
400
| – | – | ﹤0.01% | 3878 |
|
|
2023
Q2 | $9.34K | Hold |
400
| – | – | ﹤0.01% | 4388 |
|
|
2023
Q1 | $9.31K | Hold |
400
| – | – | ﹤0.01% | 4096 |
|
|
2022
Q4 | $10.1K | Hold |
400
| – | – | ﹤0.01% | 4130 |
|
|
2022
Q3 | $11K | Hold |
400
| – | – | ﹤0.01% | 4216 |
|
|
2022
Q2 | $12K | Hold |
400
| – | – | ﹤0.01% | 4545 |
|
|
2022
Q1 | $14K | Hold |
400
| – | – | ﹤0.01% | 4593 |
|
|
2021
Q4 | $18K | Hold |
400
| – | – | ﹤0.01% | 4643 |
|
|
2021
Q3 | $20K | Hold |
400
| – | – | ﹤0.01% | 4483 |
|
|
2021
Q2 | $21K | Hold |
400
| – | – | ﹤0.01% | 4594 |
|
|
2021
Q1 | $18K | Buy |
+400
| New | +$18K | ﹤0.01% | 4652 |
|